Table 2.
Multiple logistic regression models predicting 7-day point prevalence and continuous abstinence at Weeks 12, 18, and 24
| Dependent Variable: Point Prevalence Abstinence Week 12 | OR | 95% CI | P |
|---|---|---|---|
| Income (Reference=20K or less) | 1.23 | 0.78, 1.93 | 0.37 |
| Medication Adherence | 1.01 | 1.00, 1.02 | 0.12 |
| Efavirenz Use (Reference=Yes) | 2.83 | 1.04, 7.73 | 0.04 |
| TTFC (Reference=Within 30 minutes) | 0.59 | 0.22, 1.57 | 0.29 |
| Treatment Arm (Reference=Placebo) | 4.54 | 1.83, 11.25 | 0.001 |
| Dependent Variable: Point Prevalence Abstinence Week 18 | OR | 95% CI | p |
| Income (Reference=20K or less) | 1.16 | 0.75, 1.86 | 0.56 |
| Medication Adherence | 1.01 | 0.99, 1.02 | 0.31 |
| Efavirenz Use (Reference=Yes) | 1.84 | 0.62, 5.42 | 0.27 |
| TTFC (Reference=Within 30 minutes) | 0.52 | 0.18, 1.39 | 0.19 |
| Treatment Arm (Reference=Placebo) | 3.12 | 1.22, 7.97 | 0.02 |
| Dependent Variable: Point Prevalence Abstinence Week 24 | OR | 95% CI | p |
| Income (Reference=20K or less) | 1.10 | 0.64, 1.89 | 0.72 |
| Medication Adherence | 1.01 | 0.99, 1.02 | 0.30 |
| Efavirenz Use (Reference=Yes) | 1.84 | 0.58, 5.77 | 0.30 |
| TTFC (ReferencêWithin 30 minutes) | 0.60 | 0.19, 1.85 | 0.37 |
| Treatment Arm (Reference=Placebo) | 1.90 | 0.71, 5.10 | 0.20 |
| Dependent Variable: Continuous Abstinence Weeks 9–12 | OR | 95% CI | p |
| Income (Reference=20K or less) | 1.37 | 0.86, 2.18 | 0.19 |
| Medication Adherence | 1.01 | 1.00, 1.02 | 0.18 |
| Efavirenz Use (Reference=Yes) | 3.16 | 1.1, 9.1 | 0.03 |
| TTFC (Reference=Within 30 minutes) | 0.54 | 0.19, 1.52 | 0.24 |
| Treatment Arm (Reference=Placebo) | 4.65 | 1.71, 12.67 | 0.003 |
| Dependent Variable: Continuous Abstinence Weeks 9–18 | OR | 95% CI | p |
| Income (Reference=20K or less) | 1.28 | 0.76, 2.16 | 0.36 |
| Medication Adherence | 1.01 | 0.99, 1.02 | 0.27 |
| Efavirenz Use (Reference=Yes) | 2.11 | 0.65, 6.83 | 0.21 |
| TTFC (Reference=Within 30 minutes) | 0.56 | 0.18, 1.78 | 0.33 |
| Treatment Arm (Reference=Placebo) | 2.90 | 1.00, 8.43 | 0.05 |
| Dependent Variable: Continuous Abstinence Weeks 9–24 | OR | 95% CI | p |
| Income (Reference=20K or less) | 1.36 | 0.76, 2.43 | 0.31 |
| Medication Adherence | 1.01 | 0.99, 1.02 | 0.51 |
| Efavirenz Use (Reference=Yes) | 2.43 | 0.66, 8.94 | 0.18 |
| TTFC (Reference=Within 30 minutes) | 0.72 | 0.18, 2.88 | 0.64 |
| Treatment Arm (Reference=Placebo) | 1.92 | 0.57, 6.47 | 0.29 |
Note. Medication adherence was continuous measure of number of pills taken